Etidronate
CAS No. 2809-21-4
Etidronate( —— )
Catalog No. M13855 CAS No. 2809-21-4
Etidronate (Didronel) is a human protein tyrosine phosphatase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 27 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEtidronate
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtidronate (Didronel) is a human protein tyrosine phosphatase inhibitor.
-
DescriptionEtidronate (Didronel) is a human protein tyrosine phosphatase inhibitor.(In Vitro):Etidronic acid (Etidronate) (10 mM, 24 h) shows cytotoxicity, causes a decrease in the S-phase population and an increase in the G2/M population, induces p53 mutation in MCF-7 cells.Etidronic acid (100 nM, 24 h) induces osteoclast apoptosis, which displays characteristics of apoptosis, including chromatin condensation and changed cellular and nuclear morphology, detected by fluorescence microscopy.
-
In VitroEtidronic acid (Etidronate) (10 mM, 24 h) shows cytotoxicity, causes a decrease in the S-phase population and an increase in the G2/M population, induces p53 mutation in MCF-7 cells.Etidronic acid (100 nM, 24 h) induces osteoclast apoptosis, which displays characteristics of apoptosis, including chromatin condensation and changed cellular and nuclear morphology, detected by fluorescence microscopy.
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHBV
-
RecptorHAP| PTPase S| V-type proton ATPase catalytic subunit
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number2809-21-4
-
Formula Weight206.03
-
Molecular FormulaC2H8O7P2
-
Purity>98% (HPLC)
-
SolubilityWater: 41 mg/mL (199.0 mM)
-
SMILESCC(O)(P(=O)(O)O)P(=O)(O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Grases F, et al. Circ J. 2007 Jul;71(7):1152-6.
molnova catalog
related products
-
Burfiralimab
Burfiralimab (hzVSF-v13) is a monoclonal immunoglobulin (IgG4) targeted against waveform proteins, exhibiting anti-HBV properties and potential applications in rheumatoid arthritis research.
-
Canocapavir
Canocapavir (ZM-H1505R) is a novel orally available HBV coat protein modulator with antiviral activity that induces conformational changes in the linker region of the HBV core protein, and can be used for the treatment of hepatitis B virus.
-
Helioxanthin derivat...
Helioxanthin derivative 5-4-2 (Helioxanthin 5-4-2) is an analogue of helioxanthin that shows anti-HBV activity in vitro and can be used to study HBV.
Cart
sales@molnova.com